Indian Army Department Of Military Affairs Pharmaceuticals Tender 2026 B 7124101 – ISI/ISO-Grade Drugs & Topicals 861230.4

Tender Overview

The Indian Army Department Of Military Affairs seeks procurement of six pharmaceutical items including breathe-activated inhalers (salmetrol 25 mcg), glycopyrrolate ip 9 mcg MDI, Acebrophyllin 100 mg + N-acetylcystine, Darbepoietin 60 mcg injection, Decapeptide lotion, and Clindamycin phosphate topical gel. Estimated value is ₹861,230.40 with an EMD of ₹5,232. This tender permits quantity variation up to ±25% during contract execution at the contracted rates. Location details are not disclosed; however, it is a government procurement for medical supplies. The contract requires strict compliance with drug licensing, price ceilings, and batch-quality verification to ensure safety and regulatory adherence. The submission must include OEM authorization, and a notarized undertakings, and a compliance sheet with the bid number. A unique feature is the extension mechanism for increased quantity and extended delivery time as per the option clause. This tender emphasizes regulatory and quality assurances alongside price competitiveness.

Technical Specifications & Requirements

• Item scope includes: six listed pharmaceutical products (inhalers, injectable, topical gel, lotion).
• Mandatory licenses: valid CDSCO/DCGI drug license for quoted drugs.
• Pricing constraint: attach the DPCO ceiling price fixed by central/state government.
• Quality verification: provide Batch Test Certificate from a government-authorized lab or NABL.
• Manufacturer authorization: submit OEM/Original Service Provider authorization with full contact details.
• Compliance documents: include a notarized undertaking and a compliance sheet with the bid.
• Bid specifics: 6 items in the BOQ with no unit quantities disclosed; bidders should be prepared to supply as per the option clause.
• ATC documents: a pre-uploaded ATC file is referenced for reference.

Terms, Conditions & Eligibility

• EMD: ₹5,232.
• Estimated value: ₹861,230.40.
• Quantity variation: up to ±25% during contract; extended delivery timelines apply with a minimum of 30 days.
• Delivery terms: delivery schedule to be aligned with original and extended periods; timing calculated as (increased quantity/original quantity) × original delivery period, subject to minimum 30 days.
• Documentation: submit drug licenses, DPCO pricing, batch test certificates, and OEM authorizations.
• Penalties: non-acceptance due to missing NABL certificate can ban the supplier from the process.
• ATC clause: reference to uploaded ATC document; bidders must ensure compliance with all attached terms.
• Eligibility: manufacturers/authorized distributors with valid licenses and capability to supply pharmaceutical items in a government hospital setting.